Increased Number of Prostate Cancer Patients Selecting High Dose-Rate Interstitial Brachytherapy during the COVID-19 Pandemic

Since the beginning of the outbreak of the novel coronavirus (SARS-CoV-2) disease 2019 (COVID-19) in December 2019 in Wuhan, China [1], the virus rapidly spread around the globe. The virus hardly hit not only European countries, but also the United States, Brazil, and India. Subsequently, the World Health Organization has declared the COVID-19 outbreak a global pandemic on March 12th 2020 and many large cities around the world experienced lock-down. Several organizations or radiotherapy societies published guidelines or suggested solutions for cancer patient ’s management under the global COVID-19 pandemic [2–10].

Source: Radiotherapy and Oncology - November 20, 2020 Category: Radiology Authors: Naoya Murakami, Satoshi Nakamura, Tairo Kashihara, Koji Inaba, Tomoya Kaneda, Kana Takahashi, Kae Okuma, Hiroshi Igaki, Jun Itami Tags: Letter to the Editor Source Type: research